CHF Readmission Prevention Efforts Costly for Hospital
Stauffer said in the interview that Medicare non-payment policies in the event of an adverse event, such as a hospital-acquired infection, during that readmission would not make that much difference in the overall financial equation.
In the same issue of the journal, further evidence that readmissions prevention programs work was provided in another paper by Rachel Voss and colleagues of Quality Partners of Rhode Island and Alpert Medical School of Brown University in Providence.
Their report validated another model of readmission prevention effort, the Care Transitions Intervention or CTI, with 257 patients at six Rhode Island hospitals. That effort reduced readmissions by 36% compared with a control group.
However, that program met with challenges because just over half of those approached agreed to participate, and some resisted a home visit.
Low Health Literacy Linked to Mortality in CHF Patients
CHF Patients May Fare Better, Pay More at High-Volume Hospitals
12 Ways to Reduce Hospital Readmissions
$50 Blood Test Could Predict CHF Readmission Risk
Cheryl Clark is senior quality editor and California correspondent for HealthLeaders Media. She is a member of the Association of Health Care Journalists.
- Why Is Healthcare Price Transparency So Hard?
- 5 Hot Healthcare Ideas from SXSW
- EHR Spending Continues, But Jury Still Out on ROI
- Care Coordination a Cost-Cutting Quality Driver
- Adverse Events from Insulin Prescribing 'An Epidemic'
- Hospital Groups Strike Back at Hospital Rating Systems
- The Trouble with Hospital Price Transparency
- Hospital CEO Turnover Hits Record High
- Payers Detail Strategies That Drive Consumer Satisfaction
- The Secret to Physician Engagement? It's Not Better Pay